ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Inoperable Disease | 1 |
| Lung Cancer | 1 |
Recruiting trials involving ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab
Common questions
How many recruiting trials involve ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab?
1 recruiting trial across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.